WHO supports new malaria vaccine

Director General of the World Health Organization, Tedros Adhanom, in parallel with recommending the use of the first malaria vaccine named RTS,S, said WHO also recommends a second vaccine called R21/Matrix-M to prevent malaria in children at risk of this disease.

Adhanom added that: Evidence shows that, in areas where infection is seasonal, malaria is reduced by 75% after 3 doses of vaccine within 12 months. Trials have shown that injecting the fourth dose one year after the third dose maintains immunity. He emphasized that these tests have shown that this vaccine is reliable and its safety monitoring continues during distribution.

Announcing that almost half of the world is still at risk of contracting malaria, the Secretary General of the World Health Organization has explained that: "Since the year 2000, deaths from malaria have decreased by more than half, and we have succeeded in eradicating malaria in many parts of the world ."

At least 28 countries on the African continent plan to provide the malaria vaccine recommended by the World Health Organization as part of their national immunization programs.The RTS,S vaccine will be distributed in some African countries starting early next year, and the R21 vaccine will probably be sent to various countries in the middle of next year.

WHO